|
|
|
Five studies investigating bone marrow transplantation as a treatment option for women with breast
cancer are currently being discussed and analyzed, nationally. They will be presented in May at the annual meeting of the American Society for
Clinical Oncologists (ASCO). Preliminary results of the studies are being released to the public today, April 15.
One of the studies, which compared high dose chemotherapy and bone marrow transplantation
(HDC/BMT) with intermediate dose therapy (ID) and no transplant in women diagnosed with high risk breast cancer (at least 10 positive nodes), was
led by Dr. William Peters, head of the Barbara Ann Karmanos Cancer Institute.
Note:
The study did not compare high dose chemotherapy and bone marrow transplantation
with standard therapy, but with intermediate dose therapy. Neither "arm"
is considered "standard therapy."
porta potti
The study enrolled 783 women with stage II or III disease from January 1991 through May 1998.
Some 30 centers, nationally, participated in recruiting and treating patients.
|
|
|
|